Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Ointments: SOP for Testing Spreadability of Ointments – V 2.0

Posted on By

SOP for Testing Spreadability of Ointments – V 2.0

Procedure for Testing Spreadability of Ointments

Department Quality Control (QC)/Quality Assurance (QA)/Production
SOP No. SOP/Ointment/068
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a standardized method for testing the spreadability of ointments. Spreadability is a key parameter that determines the ease of application and uniformity of distribution on the skin, ensuring product efficacy and patient compliance.

2. Scope

This SOP applies to all personnel in the Quality Control (QC) and Quality Assurance (QA) departments responsible for testing the spreadability of ointments during formulation development and routine batch testing.

3. Responsibilities

  • Quality Control Analyst: Conducts spreadability testing and records results.
  • Quality Assurance Personnel: Reviews and approves test results.
  • Production Supervisor: Ensures that the ointment batches conform to spreadability requirements.
  • R&D Team (if applicable): Evaluates formulation modifications based on spreadability test results.
See also  Ointments: SOP for Formulation Development of Ointments - V 2.0

4. Accountability

The QC and QA Managers are accountable for ensuring that spreadability tests are conducted accurately and documented as per regulatory and GMP standards.

5. Procedure

5.1 Pre-Test Preparations

  • Ensure that the ointment sample is at room temperature (25°C ± 2°C).
  • Use a calibrated spreadability testing apparatus (such as a parallel plate method or glass slide method).
  • Clean all equipment, glass plates,
and measuring instruments before use.
  • Ensure that the test surface is non-absorbent and free from contaminants.
  • 5.2 Spreadability Testing Methods

    5.2.1 Parallel Plate Method

    • Weigh approximately 0.5 g to 1.0 g of ointment and place it in the center of the lower glass plate.
    • Place a second glass plate on top of the ointment.
    • Apply a known weight (e.g., 100 g, 200 g, or 500 g) onto the upper plate.
    • Allow the weight to remain for 5 minutes.
    • Measure the diameter of the spread ointment using a calibrated scale.

    5.2.2 Glass Slide Method

    • Place a small amount (approx. 0.5 g) of ointment on a fixed glass slide.
    • Press another slide on top and allow uniform spreading under its own weight.
    • After 5 minutes, gently lift the upper slide and measure the spread area.

    5.3 Calculating Spreadability

    • Spreadability is calculated using the formula:
    • S = M × L / T
    • Where:
      • S = Spreadability (g.cm/sec)
      • M = Weight applied (g)
      • L = Length of the ointment spread (cm)
      • T = Time required for spreading (sec)
    • Compare the results against the predetermined spreadability specification.

    5.4 Acceptance Criteria

    • The spreadability should be within the predefined range for the specific ointment formulation.
    • Significant deviations from the standard range may indicate formulation issues requiring further evaluation.

    5.5 Documentation

    • Record all measurements, weights applied, and results in the Spreadability Test Log.
    • Document observations such as consistency, smoothness, and ease of application.
    • QA personnel must review and approve results before batch release.

    6. Abbreviations

    • GMP – Good Manufacturing Practices
    • QA – Quality Assurance
    • QC – Quality Control
    • R&D – Research and Development

    7. Documents

    • Spreadability Test Log (Annexure-1)
    • Ointment Batch Testing Report (Annexure-2)

    8. References

    • WHO GMP Guidelines for Pharmaceutical Manufacturing
    • USP <1174> – Semisolid Drug Products
    • ICH Q2 (R1) – Validation of Analytical Procedures

    9. SOP Version

    Version 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Spreadability Test Log

    Date Batch Number Sample Weight (g) Weight Applied (g) Spread Diameter (cm) Result Verified By
    01/02/2025 OINT-101 0.5 200 5.2 Pass QA Officer
    02/02/2025 OINT-102 0.5 200 4.8 Pass QA Officer

    Annexure-2: Ointment Batch Testing Report

    Date Batch Number Test Method Acceptance Criteria Result Final Status Approved By
    01/02/2025 OINT-101 Parallel Plate 4.5 – 5.5 cm 5.2 cm Approved QA Head
    02/02/2025 OINT-102 Glass Slide 4.5 – 5.5 cm 4.8 cm Approved QA Head

    12. Revision History:

    Revision Date Revision No. Details of Revision Reason for Revision Approved By
    01/01/2024 1.0 Initial Version New SOP QA Head
    01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
    Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

    Post navigation

    Previous Post: SOP for Testing Compatibility with Packaging Materials
    Next Post: Tablets: SOP for Implementation of Lean Manufacturing in Tablet Production – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version